Pharma news
Americas
The US Court of Appeals for the Federal Circuit last week reversed a Patent Trial and Appeal Board decision, which found that claims in an OSI Pharmaceuticals patent for cancer treatment were obvious. 7 October 2019
Pharma
A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina. 4 October 2019
Americas
LSX World Congress USA brings life sciences investment and partnering to Boston. 4 October 2019
Pharma
Novartis has teamed with Microsoft to launch a new artificial intelligence innovation lab, which it says has the potential to “transform” and “reimagine” medicine. 3 October 2019
Pharma
The US Food and Drug Administration and Drug Enforcement Administration have issued joint warning letters to four online networks which allegedly sell unapproved and misbranded versions of medicines. 1 October 2019
Pharma
As lawyers and industry prepare for a possible no-deal Brexit, the uncertainty surrounding its impact is palpable, as LSIPR’s Saman Javed discovers. 1 October 2019
Pharma
LSIPR’s Sarah Morgan investigates the current state of play of M&A in the sector and predicts the next year of activity. 30 September 2019
Americas
While providing benefits to Mexico’s biologics system, the USMCA may also increase costs for citizens, argues Margarita Guerrero Gonzalez of Uhthoff, Gomez Vega & Uhthoff. 30 September 2019
Pharma
A tie-up between four leading pharmaceutical companies, the UK government and a health charity has created the world’s largest genetic research project. LSIPR’s Rory O’Neill looks at a new frontier for life sciences. 30 September 2019
Pharma
Bringing a drug to market is costing companies under $2 billion for the first time in five years, according to a report from IP service provider Clarivate Analytics. 30 September 2019